/Companies

10x Genomics

NASDAQ: TXGalso invests · investor profileUnicorn · $11.5B

Pleasanton, US · 11 known investors

Find your way into 10x Genomics

Sign up to see every warm intro you have to 10x Genomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 10x Genomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.

Founders & leadership

SSSerge Saxonov
Serge SaxonovFounderFounder at 10x Genomics 1-color
BHBen Hindson
Ben HindsonFounderFounder at 10x Genomics 1-color
BC
Brad CrutchfieldChief Commercial Officer
JPJean Philibert
Jean PhilibertChief People Officer
ESEric S Whitaker
Eric S WhitakerGeneral CounselGeneral Counsel at 10x Genomics 1-color
JM
Justin McAnearChief Financial Officer
KN
Kevin NessFounder

Investors · 11

Reported raises · per SEC filings

Form D private placements
▶Undisclosed amountofferedMay 2019 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brad CrutchfieldExecutive Officer
  • Jean PhilibertExecutive Officer
  • Ben HindsonExecutive Officer, Director
  • Eric S WhitakerExecutive Officer
  • Justin McAnearExecutive Officer
  • Serge SaxonovExecutive Officer, Director
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$11.5Bvaluation at IPOSep 2020 · $110.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

10 people who came through 10x Genomics went on to found or lead other companies.

Frequently asked questions

What does 10x Genomics do?
10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
Who founded 10x Genomics?
10x Genomics was founded by Serge Saxonov, Ben Hindson.
Who are 10x Genomics's investors?
10x Genomics's investors include Foothill Ventures, Foresite Capital, Khosla Ventures, OMX Ventures, Paladin Capital Group, SoftBank Vision Fund, Venrock, Vital Venture Capital and 3 more.
Where is 10x Genomics headquartered?
10x Genomics is headquartered in Pleasanton, US.